Cargando…

An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system

Riboswitches are bacterial RNA elements that regulate gene expression in response to metabolite or ion abundance and are considered as potential drug targets. In recent years a number of methods to find non-natural riboswitch ligands have been described. Here we report a high-throughput in vivo scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchner, Marion, Schorpp, Kenji, Hadian, Kamyar, Schneider, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552694/
https://www.ncbi.nlm.nih.gov/pubmed/28798404
http://dx.doi.org/10.1038/s41598-017-07870-w
_version_ 1783256496004399104
author Kirchner, Marion
Schorpp, Kenji
Hadian, Kamyar
Schneider, Sabine
author_facet Kirchner, Marion
Schorpp, Kenji
Hadian, Kamyar
Schneider, Sabine
author_sort Kirchner, Marion
collection PubMed
description Riboswitches are bacterial RNA elements that regulate gene expression in response to metabolite or ion abundance and are considered as potential drug targets. In recent years a number of methods to find non-natural riboswitch ligands have been described. Here we report a high-throughput in vivo screening system that allows identifying OFF-riboswitch modulators in a 384 well bioluminescence assay format. We use a reverse reporter gene setup in Bacillus subtilis, consisting of a primary screening assay, a secondary assay as well as counter assays to detect compounds in a library of 1,280 molecules that act on the guanine-responsive xpt riboswitch from B. anthracis. With this in vivo high-throughput approach we identified several hit compounds and could validate the impact of one of them on riboswitch-mediated gene regulation, albeit this might not be due to direct binding to the riboswitch. However, our data demonstrate the capability of our screening assay for bigger high-throughput screening campaigns. Furthermore, the screening system described here can not only be generally employed to detect non-natural ligands or compounds influencing riboswitches acting as genetic OFF switches, but it can also be used to investigate natural ligands of orphan OFF-riboswitches.
format Online
Article
Text
id pubmed-5552694
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55526942017-08-14 An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system Kirchner, Marion Schorpp, Kenji Hadian, Kamyar Schneider, Sabine Sci Rep Article Riboswitches are bacterial RNA elements that regulate gene expression in response to metabolite or ion abundance and are considered as potential drug targets. In recent years a number of methods to find non-natural riboswitch ligands have been described. Here we report a high-throughput in vivo screening system that allows identifying OFF-riboswitch modulators in a 384 well bioluminescence assay format. We use a reverse reporter gene setup in Bacillus subtilis, consisting of a primary screening assay, a secondary assay as well as counter assays to detect compounds in a library of 1,280 molecules that act on the guanine-responsive xpt riboswitch from B. anthracis. With this in vivo high-throughput approach we identified several hit compounds and could validate the impact of one of them on riboswitch-mediated gene regulation, albeit this might not be due to direct binding to the riboswitch. However, our data demonstrate the capability of our screening assay for bigger high-throughput screening campaigns. Furthermore, the screening system described here can not only be generally employed to detect non-natural ligands or compounds influencing riboswitches acting as genetic OFF switches, but it can also be used to investigate natural ligands of orphan OFF-riboswitches. Nature Publishing Group UK 2017-08-10 /pmc/articles/PMC5552694/ /pubmed/28798404 http://dx.doi.org/10.1038/s41598-017-07870-w Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kirchner, Marion
Schorpp, Kenji
Hadian, Kamyar
Schneider, Sabine
An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
title An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
title_full An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
title_fullStr An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
title_full_unstemmed An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
title_short An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
title_sort in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552694/
https://www.ncbi.nlm.nih.gov/pubmed/28798404
http://dx.doi.org/10.1038/s41598-017-07870-w
work_keys_str_mv AT kirchnermarion aninvivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT schorppkenji aninvivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT hadiankamyar aninvivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT schneidersabine aninvivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT kirchnermarion invivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT schorppkenji invivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT hadiankamyar invivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem
AT schneidersabine invivohighthroughputscreeningforriboswitchligandsusingareversereportergenesystem